Home LiteratureArticle Details
PMID: 19856963 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The structural basis of pregnane X receptor binding promiscuity.

Biochemistry ·Vol. 48 ·No. 48 ·2009-12-08 ·Pages 11572-81

Ngan CH, Beglov D, Rudnitskaya AN, Kozakov D, Waxman DJ, Vajda S

Abstract

The steroid and xenobiotic-responsive human pregnane X receptor (PXR) binds a broad range of structurally diverse compounds. The structures of the apo and ligand-bound forms of PXR are very similar, in contrast to most promiscuous proteins that generally adapt their shape to different ligands. We investigated the structural origins of PXR's recognition promiscuity using computational solvent mapping, a technique developed for the identification and characterization of hot spots, i.e., regions of the protein surface that are major contributors to the binding free energy. Results reveal that the smooth and nearly spherical binding site of PXR has a well-defined hot spot structure, with four hot spots located on four different sides of the pocket and a fifth close to its center. Three of these hot spots are already present in the ligand-free protein. The most important hot spot is defined by three structurally and sequentially conserved residues, W299, F288, and Y306. This largely hydrophobic site is not very specific and interacts with all known PXR ligands. Depending on their sizes and shapes, individual PXR ligands extend into two, three, or four more hot spot regions. The large number of potential arrangements within the binding site explains why PXR is able to accommodate a large variety of compounds. All five hot spots include at least one important residue, which is conserved in all mammalian PXRs, suggesting that the hot spot locations have remained largely invariant during mammalian evolution. The same side chains also show a high level of structural conservation across hPXR structures. However, each of the hPXR hot spots also includes residues with moveable side chains, further increasing the size variation in ligands that PXR can bind. Results also suggest a unique signal transduction mechanism between the PXR homodimerization interface and its coactivator binding site.

MeSH Terms
Algorithms Amino Acid Sequence Binding Sites Dimerization Humans Hydrophobic and Hydrophilic Interactions Ligands Molecular Sequence Data Peptides/chemistry,metabolism Pregnane X Receptor Protein Conformation Receptors, Steroid/chemistry,metabolism Structure-Activity Relationship Substrate Specificity
Chemicals
Ligands Peptides Pregnane X Receptor Receptors, Steroid
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Ngan Chi-Ho
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, USA.
Beglov Dmitri
Rudnitskaya Aleksandra N
Kozakov Dima
Waxman David J
Vajda Sandor
References (48)
48 references, click to expand
  1. 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin.
    Biochemistry. 2003 Feb 18;42(6):1430-8 PMID: 12578355
  2. The role of dynamic conformational ensembles in biomolecular recognition.
    Nat Chem Biol. 2009 Nov;5(11):789-96 PMID: 19841628
  3. The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges.
    Mol Endocrinol. 2005 Dec;19(12):2891-900 PMID: 15961506
  4. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.
    Eur J Immunol. 1989 Dec;19(12):2237-42 PMID: 2481588
  5. Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans.
    J Mol Recognit. 2001 Mar-Apr;14(2):110-21 PMID: 11301481
  6. Environmental phthalate monoesters activate pregnane X receptor-mediated transcription.
    Toxicol Appl Pharmacol. 2004 Sep 15;199(3):266-74 PMID: 15364542
  7. Computational mapping identifies the binding sites of organic solvents on proteins.
    Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4290-5 PMID: 11904374
  8. Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition.
    Mol Endocrinol. 2007 May;21(5):1028-38 PMID: 17327420
  9. Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques.
    Bioinformatics. 2009 Mar 1;25(5):621-7 PMID: 19176554
  10. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.
    Biochemistry. 2005 Feb 1;44(4):1193-209 PMID: 15667213
  11. Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics.
    Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6636-41 PMID: 9618464
  12. Druggability indices for protein targets derived from NMR-based screening data.
    J Med Chem. 2005 Apr 7;48(7):2518-25 PMID: 15801841
  13. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.
    Mol Endocrinol. 2000 Jan;14(1):27-39 PMID: 10628745
  14. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces.
    Nature. 2007 Dec 13;450(7172):1001-9 PMID: 18075579
  15. The nuclear pregnane X receptor regulates xenobiotic detoxification.
    J Nutr. 2003 Jul;133(7 Suppl):2444S-2447S PMID: 12840222
  16. Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin.
    Mol Endocrinol. 2005 May;19(5):1125-34 PMID: 15705662
  17. Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450.
    Biochemistry. 2006 Aug 8;45(31):9393-407 PMID: 16878974
  18. The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology.
    Cancer Treat Rev. 2007 Jun;33(4):369-80 PMID: 17451886
  19. Computational screening of phthalate monoesters for binding to PPARgamma.
    Chem Res Toxicol. 2006 Aug;19(8):999-1009 PMID: 16918238
  20. Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR).
    Environ Health Perspect. 2004 Feb;112(2):163-9 PMID: 14754570
  21. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor.
    J Mol Biol. 2003 Aug 22;331(4):815-28 PMID: 12909012
  22. The Protein Data Bank.
    Nucleic Acids Res. 2000 Jan 1;28(1):235-42 PMID: 10592235
  23. Identification of substrate binding sites in enzymes by computational solvent mapping.
    J Mol Biol. 2003 Oct 3;332(5):1095-113 PMID: 14499612
  24. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism.
    Endocr Rev. 2002 Oct;23(5):687-702 PMID: 12372848
  25. Human PXR forms a tryptophan zipper-mediated homodimer.
    Biochemistry. 2006 Jul 18;45(28):8579-89 PMID: 16834332
  26. Biochemistry. How do proteins interact?
    Science. 2008 Jun 13;320(5882):1429-30 PMID: 18556537
  27. Predicting druggable binding sites at the protein-protein interface.
    Drug Discov Today. 2009 Feb;14(3-4):155-61 PMID: 19041415
  28. Folding funnels and binding mechanisms.
    Protein Eng. 1999 Sep;12(9):713-20 PMID: 10506280
  29. Functional evolution of the vitamin D and pregnane X receptors.
    BMC Evol Biol. 2007 Nov 12;7:222 PMID: 17997857
  30. Structural insights into the promiscuity and function of the human pregnane X receptor.
    Curr Opin Drug Discov Devel. 2002 Jan;5(1):150-8 PMID: 11865669
  31. Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism.
    Bioorg Med Chem. 2007 Mar 1;15(5):2156-66 PMID: 17215127
  32. Identification of hot spots within druggable binding regions by computational solvent mapping of proteins.
    J Med Chem. 2007 Mar 22;50(6):1231-40 PMID: 17305325
  33. Active nuclear receptors exhibit highly correlated AF-2 domain motions.
    PLoS Comput Biol. 2008 Jul 11;4(7):e1000111 PMID: 18617990
  34. Locating and characterizing binding sites on proteins.
    Nat Biotechnol. 1996 May;14(5):595-9 PMID: 9630949
  35. Estrogens and antiestrogens activate hPXR.
    Toxicol Lett. 2007 Apr 5;170(1):19-29 PMID: 17379461
  36. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity.
    Science. 2001 Jun 22;292(5525):2329-33 PMID: 11408620
  37. Promiscuity: what protects us, perplexes us.
    Drug Discov Today. 2004 May 15;9(10):431-2 PMID: 15109946
  38. Machine learning methods and docking for predicting human pregnane X receptor activation.
    Chem Res Toxicol. 2008 Jul;21(7):1457-67 PMID: 18547065
  39. Structural basis for ligand promiscuity in cytochrome P450 3A4.
    Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13682-7 PMID: 16954191
  40. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor.
    Mol Pharmacol. 2001 Sep;60(3):427-31 PMID: 11502872
  41. Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites.
    Mol Pharmacol. 2007 Sep;72(3):592-603 PMID: 17576789
  42. A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.
    Pharm Res. 2002 Dec;19(12):1788-800 PMID: 12523656
  43. Regulation of cyp3a gene transcription by the pregnane x receptor.
    Annu Rev Pharmacol Toxicol. 2002;42:1-23 PMID: 11807162
  44. Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.
    Chem Res Toxicol. 2001 Dec;14(12):1596-603 PMID: 11743742
  45. Evolution of pharmacologic specificity in the pregnane X receptor.
    BMC Evol Biol. 2008 Apr 02;8:103 PMID: 18384689
  46. A hot spot of binding energy in a hormone-receptor interface.
    Science. 1995 Jan 20;267(5196):383-6 PMID: 7529940
  47. Structural basis of human pregnane X receptor activation by the hops constituent colupulone.
    Mol Pharmacol. 2008 Dec;74(6):1512-20 PMID: 18768384
  48. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.
    Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12208-13 PMID: 9770465
Article Info
Journal
Biochemistry
Abbr.
Biochemistry
ISSN
1520-4995
Published
2009-12-08
Pages
11572-81
Language
English
Region
United States
NLM ID
0370623
PMCID
PMC2789303
Subset
IM
Grants
NIEHS NIH HHS · P42 ES007381-159002 · United States
NIEHS NIH HHS · P42 ES007381-149002 · United States
NIEHS NIH HHS · P42 ES007381-069002 · United States
NIEHS NIH HHS · P42 ES007381-079002 · United States
NIEHS NIH HHS · P42 ES007381-099002 · United States
NIEHS NIH HHS · P42ES07381 · United States
NIGMS NIH HHS · GM64700 · United States
NIEHS NIH HHS · P42 ES007381-109002 · United States
NIEHS NIH HHS · P42 ES007381-15S29002 · United States
NIEHS NIH HHS · P42 ES007381-089002 · United States
NIEHS NIH HHS · P42 ES007381-119002 · United States
NIEHS NIH HHS · P42 ES007381-15S19002 · United States
NIGMS NIH HHS · R01 GM064700-08 · United States
NIEHS NIH HHS · P42 ES007381-15S39002 · United States
NIEHS NIH HHS · P42 ES007381 · United States
NIEHS NIH HHS · P42 ES007381-129002 · United States
NIEHS NIH HHS · P42 ES007381-08S19002 · United States
NIEHS NIH HHS · P42 ES007381-139002 · United States
NIGMS NIH HHS · R01 GM064700 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com